Based on these preclinical data, the genes transcriptionally regulated by Mbd2 within the immune system and stem cells from the normal and diseased intestinal epithelia offer a set of targets that play a key role in linking epigenetic changes to cancer. The gene discussed is MBD2; the disease is cancer.